Oligometastatic Breast Cancer: How to Manage It?

Area of Science:

• Oncology
• Medical research

Background:

• Breast cancer (BC) is a leading cause of cancer death in women.
• Oligometastatic breast cancer (OMBC) is a subset of metastatic disease with limited spread.
• OMBC presents an opportunity for curative-intent treatment strategies.

Purpose of the Study:

• To provide a global perspective on current treatment paradigms for OMBC.
• To discuss curative intent strategies for OMBC.
• To highlight the role of local ablative options and systemic therapies.

Main Methods:

• Review of current treatment strategies for OMBC.
• Discussion of locoregional treatments (surgery, radiotherapy).
• Analysis of systemic therapies (target therapy, immunotherapy, CDK4/6 inhibitors).

Main Results:

• Locoregional treatments and systemic therapies show potential for OMBC management.
• CDK4/6 inhibitors improve progression-free survival (PFS) and overall survival (OS) in HR+/HER-2 negative BC.
• Local ablative options show encouraging results but are limited by retrospective data and selection bias.

Conclusions:

• OMBC can be managed with curative intent using a combination of approaches.
• Multidisciplinary and aggressive treatment strategies are recommended for OMBC.
• Further research is needed, but OMBC patients, especially younger women, may benefit from these intensive approaches.